<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Success treating equine sarcoids with immunotherapy</title><link>/b/veterinary-news/posts/success-treating-equine-sarcoids-with-immunotherapy</link><description> Viennese biotech company BlueSky Immunotherapies says it has used its viral vector platform delNS to treat sarcoids in horses successfully, paving the way for a new cancer therapy in humans. 
 BlueSky says that conventional treatment for equine sarcoids</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>